(Photographer: Andrew Harrer/Bloomberg)

Disclosure: I have no positions in Goldman Sachs, Caterpillar, JPMorgan Chase, American Express or UnitedHealth.

Goldman Sachs is the biggest gainer since the close on election day followed by Caterpillar, JPMorgan, American Express and UnitedHealth.

The Dow Jones Industrial Average set an all-time intraday high of 19,083.76 on Wednesday, a gain of 9.5% year-to-date and a bull market run-up of 23.5% since trading as low as 15,450.56 on Jan. 20. What’s interesting is that when the Dow traded above 19,000 for the first time ever this week, not a single component set a new all-time intraday high.

The “Trump bump” since the Nov. 8 election close, has thus been fueled by stocks that were laggards until President-Elect Trump won the day. Three of the big winners are in the financial sector, one in the industrial sector and one in the health insurance industry.

Here’s the weekly chart for the Dow Jones Industrial Average.

Courtesy of MetaStock Xenith

The weekly chart for the Dow 30 is positive with the average above its five-week modified moving average of 18,540.31, and well above its 200-week simple moving average of 16,825.63, last tested during the week of Feb. 12 when the average was 15,819.45. The 12x3x3 weekly slow stochastic reading is projected to rise to 62.31 this week, up from 44.95 on Nov. 18.

My proprietary analytics still show weekly and quarterly value levels of 18,509 and 18,326 with my risky level for November at 19,617. My annual value level remains at 14,592 with a semiannual risky level of 20,485.

Here’s a scorecard for the five Dow gainers helping the Dow to its new high.

Goldman Sachs (GS) closed at $212.31 on Nov. 23, up 16.7% since Nov. 8 and in bull market territory, 53.6% above its June 27 low of $138.20. Investors must be anticipating improved deal flow under President Trump.

Courtesy of MetaStock Zenith

Goldman’s weekly chart is positive but overbought with the stock above its five-week modified moving average of $180.73 and above its 200-week simple moving average of $172.30, which was the launching-pad during the week of Oct. 21. The stock’s 12x3x3 weekly slow stochastic reading is projected to rise to 92.17 this week, up from 89.49 on Nov. 18, becoming extremely overbought above the threshold of 80.00.

Investors looking to buy Goldman should do so on weakness to $172.30, which is the 200-week simple moving average. Investors looking to reduce holdings should do so on strength to my semiannual risky level of $218.33.

Caterpillar (CAT) closed at $96.18 on Nov. 23, up 13.6% since Nov. 8 and in bull market territory, 70.7% above its Jan. 20 low of $56.36. Investors must be anticipating demand for new construction vehicles for infrastructure spending programs under President Trump. This stock has been one of my recommendations for 2016, as the stock is one of the eight “Dogs of the Dow” for 2016.

Courtesy of MetaStock Xenith

Caterpillar’s weekly chart is positive with the stock above its five-week modified moving average of $89.10 and above its 200-week simple moving average of $85.93, which was the election launching-pad during the week of Nov. 11. The stock’s 12x3x3 weekly slow stochastic reading is projected to rise to 70.29 this week, up from 61.22 on Nov. 18.

Investors looking to buy Caterpillar should do so on weakness to $85.93, which is the 200-week simple moving average. Investors looking to reduce holdings should do so on strength to $111.46, which is the July 16, 2014 high.

Courtesy of MetaStock Xenith

JPMorgan Chase (JPM) closed at of $78.86 on Nov. 23, up 12.6% since Nov. 8 and in bull market territory, 50.2% above its Feb. 11 low of $52.50. Investors who were fortunate enough to own this stock this year should reduce holdings as the stock has tested an uptrend resistance line that connects the highs going back to the week of May 31, 2013. As a “too big to fail” money center bank, JPMorgan faces the risk of a breakup on a potential modern-day revival of features of the Glass-Steagall Act. In addition, FDIC data for the third quarter, to be released soon, will show stress on net interest margins, risky loans to the oil & gas industry, and exposures to derivatives not yet resolved on the unknowns of implementing Brexit in March.

JPMorgan’s weekly chart is positive but overbought with the stock above its five-week modified moving average of $72.59 and above its 200-week simple moving average of $59.59. The stock’s 12x3x3 weekly slow stochastic reading is projected to rise to 83.41 this week up from 80.57 on Nov. 18, becoming more overbought above the threshold of 80.00.

Investors looking to buy JPMorgan should do so on weakness to $66.97, which is my quarterly pivot. Investors looking to reduce holdings should do so between my semiannual pivot at $78.20 and chart resistance at $79.87.

American Express (AXP) closed at $72.88 on Nov. 23, up 8.7% since Nov. 8 and in bull market territory, 45% above its Feb. 11 low of $50.27. I am concerned above rising credit card debt so this stock should be on your “book profits on strength” list.

Courtesy of MetaStock Xenith

The weekly chart is positive but overbought with the stock above its five-week modified moving average of $68.06, but below its 200-week simple moving average of $76.52. The stock’s 12x3x3 weekly slow stochastic reading is projected to rise to 81.42 this week, up from 74.43 on Nov. 18, becoming overbought above the threshold of 80.00.

Investors looking to buy American Express should do so on weakness to $65.65, which is my annual pivot. Investors looking to reduce holdings should do so at $76.52, which is the 200-week simple moving average.

UnitedHealth (UNH) closed at $153.54 on Nov. 23, up 7.4% since Nov. 8 and in bull market territory, 42.8% above its Jan. 14 low of $107.51. The stock had been benefiting from ObamaCare, but then suffered losses through the exchanges in 2015, and thus has cut back participation significantly. The stock regained momentum on President-Elect Trump’s pledge to repeal and replace ObamaCare. The stock is becoming overbought since trading above the uptrend connecting the 2015 and mid-2016 highs. I am concerned about the uncertainties building around health care in the U.S.

Courtesy of MetaStock Xenith

UNH’s weekly chart is positive with the stock above its five-week modified moving average of $144.57, and well above its 200-week simple moving average of $99.57. The stock’s 12x3x3 weekly slow stochastic reading is projected to rise to 70,.62 this week, up from 60.93 on Nov. 18.

Investors looking to buy UnitedHealth should do so on weakness to $143.79, which is my weekly value level for next week. Investors looking to reduce holdings should do so at $153.54 to $155.87, which are my semiannual pivot and monthly risky levels, respectively. Investors could have accomplished this strategy over the past two weeks.

—–

Page 6 / 6

Comment on this story